argus

AstraZeneca Pharma India Ltd.

NSE: ASTRAZENINE203A0102017,345 Cr

Timeline

Time (IST)TypeMEventSrc
20 May, 03:37 pmAstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Tuesday, May 26, 2026bse
12 May, 06:57 pmAstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
12 May, 06:50 pmAstraZeneca Pharma India Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
12 May, 02:07 pmAstraZeneca Pharma India Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.nse
12 May, 01:55 pmAstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Associationbse
10 Apr, 05:48 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
10 Apr, 05:17 pmAstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
31 Mar, 07:48 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
31 Mar, 07:42 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnelbse
20 Mar, 12:10 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
20 Mar, 12:08 pmAstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
17 Mar, 03:07 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
17 Mar, 03:05 pmAstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
11 Mar, 04:39 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
11 Mar, 04:35 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnelbse
18 Feb, 03:33 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
18 Feb, 03:30 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Ratingbse
11 Feb, 07:05 pmAstraZeneca Pharma India Limited has informed the Exchange regarding Board meeting held on February 11, 2026.nse
11 Feb, 07:00 pmAstraZeneca Pharma India Ltd - 506820 - Outcome Of The Board Meeting Held On Wednesday, February 11, 2026bse
11 Feb, 05:50 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
11 Feb, 05:45 pmAstraZeneca Pharma India Ltd - 506820 - Appointment of Company Secretary and Compliance Officerbse
10 Feb, 10:56 amAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
10 Feb, 10:52 amAstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
02 Feb, 06:14 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
02 Feb, 06:12 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Ratingbse
31 Jan, 01:44 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
31 Jan, 01:41 pmAstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
31 Jan, 01:37 pmAstraZeneca Pharma India Ltd - 506820 - Board Meeting Intimation for Considering And Approval Of The Unaudited Financial Results Of The Company For The Quarter Ended December 31, 2025.bse
29 Jan, 05:05 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
29 Jan, 05:01 pmAstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
16 Jan, 06:48 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
16 Jan, 06:43 pmAstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
09 Jan, 11:51 amAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
09 Jan, 11:50 amAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Senior Management Personnelbse
17 Dec, 08:58 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
17 Dec, 08:55 pmAstraZeneca Pharma India Ltd - 506820 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015bse
08 Dec, 07:56 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
08 Dec, 07:33 pmAstraZeneca Pharma India Ltd - 506820 - Determination Of Materiality - Details Of Key Managerial Personnelbse
27 Nov, 08:05 pmAstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
27 Nov, 08:02 pmAstraZeneca Pharma India Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
18 Nov, 04:03 pmAstraZeneca Pharma India Ltd - 506820 - Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
18 Nov, 04:00 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
17 Nov, 03:42 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
17 Nov, 03:40 pmAstraZeneca Pharma India Ltd - 506820 - Intimation About Second Brand Partnership Between Astrazeneca Pharma India Limited ("Company") And Sun Pharmaceuticals Industries Limited For Sodium Zirconium Cyclosilicate Powder For Oral Suspension 5 Gbse
10 Nov, 10:15 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
10 Nov, 05:24 pmAstraZeneca Pharma India Limited has informed the Exchange about General Updatesnse
10 Nov, 04:36 pmAstraZeneca Pharma India Limited has informed regarding the resignation of Company Secretary and Compliance Officernse
10 Nov, 04:34 pmAstraZeneca Pharma India Limited has informed regarding Disclosure of material issuense
10 Nov, 04:32 pmAstraZeneca Pharma India Limited has informed regarding Disclosure of material issuense
10 Nov, 04:30 pmAstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officerbse